These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 20179697)

  • 1. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation.
    Mueller-Lissner S; Kamm MA; Wald A; Hinkel U; Koehler U; Richter E; Bubeck J
    Am J Gastroenterol; 2010 Apr; 105(4):897-903. PubMed ID: 20179697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
    Quigley EM; Vandeplassche L; Kerstens R; Ausma J
    Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation.
    Wulkow R; Vix JM; Schuijt C; Peil H; Kamm MA; Jordan C
    Int J Clin Pract; 2007 Jun; 61(6):944-50. PubMed ID: 17504357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral bisacodyl is effective and well-tolerated in patients with chronic constipation.
    Kamm MA; Mueller-Lissner S; Wald A; Richter E; Swallow R; Gessner U
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):577-83. PubMed ID: 21440672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation.
    Dipalma JA; Cleveland MV; McGowan J; Herrera JL
    Am J Gastroenterol; 2007 Jul; 102(7):1436-41. PubMed ID: 17403074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study.
    Kienzle-Horn S; Vix JM; Schuijt C; Peil H; Jordan CC; Kamm MA
    Aliment Pharmacol Ther; 2006 May; 23(10):1479-88. PubMed ID: 16669963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tegaserod in chronic constipation in men.
    Fried M; Johanson JF; Gwee KA; Wagner A; Pecher E; Rueegg P
    Am J Gastroenterol; 2007 Feb; 102(2):362-70. PubMed ID: 17156137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of linaclotide for patients with chronic constipation.
    Lembo AJ; Kurtz CB; Macdougall JE; Lavins BJ; Currie MG; Fitch DA; Jeglinski BI; Johnston JM
    Gastroenterology; 2010 Mar; 138(3):886-95.e1. PubMed ID: 20045700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophin-3 improves functional constipation.
    Parkman HP; Rao SS; Reynolds JC; Schiller LR; Wald A; Miner PB; Lembo AJ; Gordon JM; Drossman DA; Waltzman L; Stambler N; Cedarbaum JM;
    Am J Gastroenterol; 2003 Jun; 98(6):1338-47. PubMed ID: 12818279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study.
    Kamm MA; Müller-Lissner S; Talley NJ; Tack J; Boeckxstaens G; Minushkin ON; Kalinin A; Dzieniszewski J; Haeck P; Fordham F; Hugot-Cournez S; Nault B
    Am J Gastroenterol; 2005 Feb; 100(2):362-72. PubMed ID: 15667494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation.
    Di Palma JA; Cleveland MV; McGowan J; Herrera JL
    Am J Gastroenterol; 2007 Sep; 102(9):1964-71. PubMed ID: 17573794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study.
    Zangaglia R; Martignoni E; Glorioso M; Ossola M; Riboldazzi G; Calandrella D; Brunetti G; Pacchetti C
    Mov Disord; 2007 Jul; 22(9):1239-44. PubMed ID: 17566120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative.
    DiPalma JA; DeRidder PH; Orlando RC; Kolts BE; Cleveland MB
    Am J Gastroenterol; 2000 Feb; 95(2):446-50. PubMed ID: 10685748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
    Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE
    Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label, dose-ranging pilot study of 4 weeks of low-dose therapy with sodium phosphate tablets in chronically constipated adults.
    Medoff J; Katz S; Malik P; Pambianco D; Pruitt R; Poulos J; Rank J; Rose M
    Clin Ther; 2004 Sep; 26(9):1479-91. PubMed ID: 15531010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study.
    Cleveland MV; Flavin DP; Ruben RA; Epstein RM; Clark GE
    South Med J; 2001 May; 94(5):478-81. PubMed ID: 11372795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.